Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Open access
Girmenia, Corrado, Raiola, Anna Maria, Piciocchi, Alfonso, Algarotti, Alessandra, Stanzani, Marta, Cudillo, Laura, Pecoraro, Clara, Guidi, Stefano, Iori, Anna Paola, Montante, Barbara, Chiusolo, Patrizia, Lanino, Edoardo, Carella, Angelo Michele, Zucchetti, Elisa, Bruno, Benedetto, Irrera, Giuseppe, Patriarca, Francesca, Baronciani, Donatella, Musso, Maurizio, Prete, Arcangelo, Risitano, Antonio Maria, Russo, Domenico, Mordini, Nicola, Pastore, Domenico, Vacca, Adriana, Onida, Francesco, Falcioni, Sadia, Pisapia, Giovanni, Milone, Giuseppe, Vallisa, Daniele, Olivieri, Attilio, Bonini, Alessandro, Castagnola, Elio, Sica, Simona, Majolino, Ignazio, Bosi, Alberto, Busca, Alessandro, Arcese, William, Bandini, Giuseppe, Bacigalupo, Andrea, Rambaldi, Alessandro, Locasciulli, Anna · 2014 · Biology of Blood and Marrow Transplantation

Abstract

Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be useful to identify subpopulations who might benefit from targeted treatment strategies. The Gruppo Italiano Trapianto Midollo Osseo (GITMO) prospectively registered data on 1858 consecutive patients undergoing allo-HSCT between 2008 and 2010. Logistic regression analysis was performed to identify risk factors for proven/probable IFD (PP-IFD) during the early (days 0 to 40), late (days 41 to 100), and very late (days 101 to 365) phases after allo-HSCT and to evaluate the impact of PP-IFDs on 1-year overall survival. The cumulative incidence of PP-IFDs was 5.1% at 40 days, 6.7% at 100 days, and 8.8% at 12 months post-transplantation. Multivariate analysis identified the following variables as associated with PP-IFDs: transplant from an unrelated volunteer donor or cord blood, active acute leukemia at the time of transplantation, and an IFD before transplantation in the early phase; transplant from an unrelated volunteer donor or cord blood and grade II-IV acute graft-versus-host disease (GVHD) in the late phase; and grade II-IV acute GVHD and extensive chronic GVHD in the very late phase. The risk for PP-IFD was significantly higher when acute GVHD was followed by chronic GVHD and when acute GVHD occurred in patients undergoing transplantation with grafts from other than matched related donors. The presence of PP-IFD was an independent factor in long-term survival (hazard ratio, 2.90; 95% confidence interval, 2.32 to 3.62; P < .0001). Our findings indicate that tailored prevention strategies may be useful in subpopulations at differing levels of risk for PP-IFDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbmt.2014.03.004

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Girmenia, C., Raiola, A. M., Piciocchi, A., Algarotti, A., Stanzani, M., Cudillo, L., Pecoraro, C., Guidi, S., Iori, A. P., Montante, B., Chiusolo, P., Lanino, E., Carella, A. M., Zucchetti, E., Bruno, B., Irrera, G., Patriarca, F., Baronciani, D., Musso, M., Prete, A., Risitano, A. M., Russo, D., Mordini, N., Pastore, D., Vacca, A., Onida, F., Falcioni, S., Pisapia, G., Milone, G., Vallisa, D., Olivieri, A., Bonini, A., Castagnola, E., Sica, S., Majolino, I., Bosi, A., Busca, A., Arcese, W., Bandini, G., Bacigalupo, A., Rambaldi, A., & Locasciulli, A.
Venue
Biology of Blood and Marrow Transplantation
Publisher
Elsevier BV
Published
2014-06
Volume
20
Issue
6
Pages
872-880
ISSN
1083-8791 (ISSN-L)
OpenAlex
W2049878654
Cited by
179
References
6
FWCI
10.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.